JOSEPH FANELLI: Open Payments
NPI 1205962495 · MUNSTER, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$136,093 in 118 payments from 7 companies in 2025. Trend: 2023 $56,883 · 2024 $130,999 · 2025 $136,093
Honoraria: $75,981Speaker / faculty: $48,784Consulting: $5,550Food & beverage: $3,389Travel & lodging: $2,389
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 55 | $79,403 |
| Otsuka America Pharmaceutical, Inc. | 41 | $43,465 |
| Alkermes, Inc. | 16 | $13,068 |
| ABBVIE INC. | 3 | $80 |
| Luye Pharma (USA) Ltd. | 1 | $30 |
| Janssen Pharmaceuticals, Inc | 1 | $28 |
| Lundbeck LLC | 1 | $20 |
Products named: Auvelity, ABILIFY MAINTENA, LYBALVI, ABILIFY ASIMTUFII, VRAYLAR, ERZOFRI EXTENDED-RELEASE, SPRAVATO, VIVITROL.
Industry payments across IN — which companies pay providers there.
